David Javalera

Dr. David Javalera

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
GEGracia Viviana González Enríquez
Gracia Viviana González Enríquez
BTBlanca Miriam Torres-Mendoza
Blanca Miriam Torres-Mendoza
MEMartha Escoto-Delgadillo
Martha Escoto-Delgadillo
ECEfrain Chavarria-Avila
Efrain Chavarria-Avila
SESagrario Karina Esparza
Sagrario Karina Esparza
DJDavid Javalera
David Javalera
Background: Climate change has contributed to the global resurgence of dengue, with a spike of more than 14.4 million dengue cases. This study aimed to analyze the association between dengue frequency with climatic factors, circulating serotypes, and disease severity in northwestern Mexico. Methods: A retrospective time-series study was conducted using dengue molecular diagnostic data reported between September 2017 and January 2025 by the Laboratorio de Apoyo a la Vigilancia e Investigación Epidemiológica del Centro de Investigación Biomédica de Occidente, Mexico. Data included dengue frequency, serotype distribution, and clinical severity across seven states in northwestern Mexico (Colima, Guanajuato, Jalisco, Michoacán, Nayarit, Sinaloa, and Sonora). Meteorological data were obtained from the Automatic Meteorological Stations of the National Water Commission. Associations between dengue frequency and climatic variables were evaluated using linear regression models. Statistical analyses were performed using SPSS v24 and R v3.5. Results: In Jalisco, minimum, mean and maximum temperatures, as well as precipitation, were significant predictors of dengue cases, explaining approximately 21.7% of the variance (adjusted R2 = 0.217, p < 0.001). In Colima and Michoacán, precipitation showed no predictive value. In Guanajuato, the maximum temperature was excluded from the model (adjusted R2 = 0.226). Models for Nayarit, Sinaloa, and Sonora excluded two or more climatic variables, with adjusted R2 values of 0.111, 0.151, and 0.049, respectively. Conclusions: Climatic conditions and epidemiological time trends explain a modest proportion of dengue cases in northwestern Mexico, with the strongest association observed in Jalisco. Additional determinants, including vector ecology, host immunity, circulating serotypes, population mobility, and public health interventions, should be considered to better understand dengue dynamics.

1 October 2026 in Medical Sciences
Verified
Journal Article
Open access
PDF file
AGAsbiel Felipe Garibaldi-Ríos
Asbiel Felipe Garibaldi-Ríos
Martha GallegosMartha Gallegos
Martha Gallegos
JGJesús Magdiel García-Díaz
Jesús Magdiel García-Díaz
BGBelinda Claudia Gómez-Meda
Belinda Claudia Gómez-Meda
JMJazmin Marquez-Pedroza
Jazmin Marquez-Pedroza
BTBlanca Miriam Torres-Mendoza
Blanca Miriam Torres-Mendoza
Heart and vascular complications now rank among the leading health threats facing individuals with HIV, a reality that continues even when modern drug regimens successfully silence viral replication. Sustained immune system overdrive and persistent low-grade systemic inflammation appear central to this heightened vulnerability. This narrative review integrates current understanding of how inflammatory signaling molecules, particularly interleukins, connect to heightened cardiovascular danger in HIV-positive populations, while exploring mechanistic underpinnings, cohort-derived evidence, and prospective treatment possibilities. Elevated concentrations of proinflammatory messengers such as IL-6 and IL-18, alongside indicators of myeloid cell activation including sCD14 and sCD163, characterize the HIV-positive state and independently forecast arterial disease progression, clinical cardiac events, and shortened survival. Notably, this inflammatory signature endures despite pharmacologically induced viral quiescence. Disturbances in protective lipoprotein function, heightened clotting propensity, and leakage of gut-derived bacterial components into the bloodstream each amplify vascular injury. Inflammatory cytokines occupy a central position in HIV-associated cardiovascular pathobiology, serving dual roles as disease predictors and candidate treatment targets. Importantly, recent evidence from the REPRIEVE randomized clinical trial demonstrated that pitavastatin therapy reduced major adverse cardiovascular events by approximately 35% in people living with HIV receiving antiretroviral therapy, highlighting inflammation-modulating strategies as a new foundation of cardiovascular prevention in this population.